Suppr超能文献

Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection.

作者信息

Polyak Stephen J, Ferenci Peter, Pawlotsky Jean-Michel

机构信息

Department of Laboratory Medicine, University of Washington, Seattle, WA 98104, USA.

出版信息

Hepatology. 2013 Mar;57(3):1262-71. doi: 10.1002/hep.26179.

Abstract
摘要

相似文献

5
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review.
Adv Ther. 2020 Apr;37(4):1279-1301. doi: 10.1007/s12325-020-01251-y. Epub 2020 Feb 17.
6
Silymarin for HCV infection.
Antivir Ther. 2013;18(2):141-7. doi: 10.3851/IMP2402. Epub 2012 Sep 25.
7
Antiviral effects of silymarin against hepatitis C: the jury is still out.
Hepatology. 2008 Jul;48(1):345-6. doi: 10.1002/hep.22235.
8
Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized Silymarin.
Gastroenterology. 2007 May;132(5):1925-36. doi: 10.1053/j.gastro.2007.02.038. Epub 2007 Feb 21.
9
Meta-analysis: silymarin and its combination therapy for the treatment of chronic hepatitis B.
Eur J Clin Microbiol Infect Dis. 2013 May;32(5):657-69. doi: 10.1007/s10096-012-1789-1. Epub 2012 Dec 18.
10
Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review.
Ann Med. 2022 Dec;54(1):1548-1560. doi: 10.1080/07853890.2022.2069854.

引用本文的文献

5
The effects of silymarin consumption on inflammation and oxidative stress in adults: a systematic review and meta-analysis.
Inflammopharmacology. 2024 Apr;32(2):949-963. doi: 10.1007/s10787-023-01423-6. Epub 2024 Feb 19.
6
Effects of L. Seed Extracts on Multi Drug Resistant (MDR) Bacteria.
Molecules. 2023 Dec 21;29(1):64. doi: 10.3390/molecules29010064.
7
Dendropanoxide Alleviates Thioacetamide-induced Hepatic Fibrosis via Inhibition of ROS Production and Inflammation in BALB/ Mice.
Int J Biol Sci. 2023 May 11;19(9):2630-2647. doi: 10.7150/ijbs.80743. eCollection 2023.
8
The Effect of Bioactive Aliment Compounds and Micronutrients on Non-Alcoholic Fatty Liver Disease.
Antioxidants (Basel). 2023 Apr 10;12(4):903. doi: 10.3390/antiox12040903.
10
Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions.
J Evid Based Integr Med. 2022 Jan-Dec;27:2515690X211068826. doi: 10.1177/2515690X211068826.

本文引用的文献

1
Failure of Intravenous Silibinin Monotherapy to Prevent Hepatitis C Genotype 2A Liver Graft Reinfection.
Hepat Mon. 2012 Jun;12(6):411-4. doi: 10.5812/hepatmon.6135. Epub 2012 Jun 30.
2
Silibinin inhibits HIV-1 infection by reducing cellular activation and proliferation.
PLoS One. 2012;7(7):e41832. doi: 10.1371/journal.pone.0041832. Epub 2012 Jul 25.
4
High-dose silibinin rescue treatment for HCV-infected patients showing suboptimal virologic response to standard combination therapy.
J Viral Hepat. 2012 Aug;19(8):547-53. doi: 10.1111/j.1365-2893.2011.01572.x. Epub 2011 Dec 29.
5
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial.
Free Radic Biol Med. 2012 May 1;52(9):1658-65. doi: 10.1016/j.freeradbiomed.2012.02.008. Epub 2012 Feb 15.
7
Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C.
Drug Metab Dispos. 2011 Dec;39(12):2182-90. doi: 10.1124/dmd.111.040212. Epub 2011 Aug 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验